Status:
NOT_YET_RECRUITING
Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Bone Neoplasms
Soft Tissue Neoplasms
Eligibility:
All Genders
Brief Summary
Investigate the application protocol, feasibility, and efficacy of indocyanine green (ICG)-assisted near-infrared (NIR) fluorescence-guided resection in bone and soft tissue tumors. Assess the inciden...
Detailed Description
This research focuses on improving surgical outcomes for patients with bone and soft tissue tumors, a challenging area of cancer treatment. Surgeons face a critical dilemma: removing too much tissue c...
Eligibility Criteria
Inclusion
- Histologically confirmed diagnosis of bone and soft tissue tumors (according to the WHO Classification of Tumours of Soft Tissue and Bone, 4th Edition).
- Medically fit to undergo surgical treatment based on preoperative evaluation.
- Absence of cardiovascular, anesthesia-related, or other surgical contraindications.
Exclusion
- Presence of severe or chronic kidney, liver, or pulmonary diseases.
- Autonomous thyroid nodules or allergy to iodine/shellfish.
- Deemed unable to tolerate surgery based on preoperative evaluation.
Key Trial Info
Start Date :
May 25 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06979115
Start Date
May 25 2025
End Date
December 31 2028
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China, 516008